Loading…

Grant Application Form

Complete all steps to submit your application

Pre-filled from selected grant
CRUKD/24/002 A CRUK Phase II open label trial in participants with metastatic pancreatic adenocarcinoma (PDAC) of ginisortamab (UCB6114), a first in class anti-gremlin1 mAb, given iv with 1st line SOC nab-paclitaxel & gemcitabine or in combination with MEK inhibitor maintenance therapy

Cancer Research UK · United Kingdom

Grant Information

Provide details about the grant you are applying for


$
Applicant Information

Tell us about yourself and your organization


$
Proposal & Supporting Documents

Provide additional details and upload your proposal document


Accepted formats: PDF, DOC, DOCX. Max size: 10MB